Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
Public ClinicalTrials.gov record NCT03370120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Extension Study to Evaluate the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects With Drug-Resistant Epilepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the long-term safety and tolerability of Padsevonil administered at individualized doses as adjunctive treatment for subjects with drug-resistant epilepsy.
Study identification
- NCT ID
- NCT03370120
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 406 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2018 (Actual)
- Primary completion
- Dec 11, 2020 (Actual)
- Completion
- Dec 11, 2020 (Actual)
- Last update posted
- Dec 29, 2021
2018 – 2020
United States locations
- U.S. sites
- 25
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ep0093 839 | Chandler | Arizona | 85226 | — |
| Ep0093 815 | La Jolla | California | 92037 | — |
| Ep0093 801 | San Francisco | California | 94115 | — |
| Ep0093 803 | Honolulu | Hawaii | 96817 | — |
| Ep0093 638 | Fort Wayne | Indiana | 46804 | — |
| Ep0093 707 | Lexington | Kentucky | 40536 | — |
| Ep0093 822 | Baltimore | Maryland | 21287 | — |
| Ep0093 818 | Bethesda | Maryland | 20817 | — |
| Ep0093 889 | Boston | Massachusetts | 02215 | — |
| Ep0093 645 | Golden Valley | Minnesota | 55422 | — |
| Ep0093 817 | Saint Paul | Minnesota | 55102 | — |
| Ep0093 806 | Hackensack | New Jersey | 07601 | — |
| Ep0093 893 | Syracuse | New York | 13210 | — |
| Ep0093 895 | The Bronx | New York | 10467-24 01 | — |
| Ep0093 890 | Chapel Hill | North Carolina | 27514 | — |
| Ep0093 884 | Charlotte | North Carolina | 28204 | — |
| Ep0093 642 | Columbia | Ohio | 43210 | — |
| Ep0093 802 | Philadelphia | Pennsylvania | 19107 | — |
| Ep0093 838 | Cordova | Tennessee | 38018 | — |
| Ep0093 835 | Nashville | Tennessee | 37232 | — |
| Ep0093 805 | Austin | Texas | 78701 | — |
| Ep0093 844 | Austin | Texas | 78758 | — |
| Ep0093 824 | Round Rock | Texas | 78681 | — |
| Ep0093 870 | San Antonio | Texas | 78229 | — |
| Ep0093 639 | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03370120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 29, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03370120 live on ClinicalTrials.gov.